Indeed, TBX2 expression correlates with poor prognosis in glioblastoma (GBM) and CRC; invasion and metastasis in lung, breast, pancreatic, prostate, nasopharyngeal, gastric and CRC; tumour recurrence in gastric cancer; and lymph node metastasis in cervical cancer and endometrial adenocarcinoma [26,33–46]. This evidence concerns the gene TBX2 and colorectal carcinoma.